Trial intelligence / Profile preview

Aqueous Humor Dynamics and IOP Variance

NCT01677507Phase 4Completed

Sponsor
University of Michigan
Start
Aug 2012
Primary completion
Aug 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4 trial of timolol and latanoprost in Glaucoma, sponsored by University of Michigan. Primary endpoint: Variation in Intraocular Pressure Between Individuals at 1 week. Started Aug 2012; status: completed.

02

Drugs

timolollatanoprost
03

Conditions

Glaucoma

Beyond the preview

Go deeper on NCT01677507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01677507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call